Genetic variation in NEDD4L, an epithelial sodium channel regulator, is associated with cardiovascular disease and cardiovascular death

Objectives: We have previously shown that genetic variance in NEDD4L, a regulating protein of a sodium channel in the distal nephron, has been associated with marginally higher blood pressure and enhanced salt sensitivity. Here, we tested if the genetic NEDD4L variation previously associated with salt sensitivity is related to population blood pressure, incidence of cardiovascular disease (CVD) and mortality. Method: We genotyped the rs4149601 A→G and rs2288774 T→C NEDD4L variants in 27 564 participants of the Malmö Diet and Cancer Study. The genotype combination previously shown to be associated with salt sensitivity (rs4149601 GG+rs2288774 CC), which was present in 9.6% of participants, was related to cross sectional blood pressure as well as to CVD incidence and mortality during a median follow-up time of 14 years using Cox regression models. Results: Carriers of the NEDD4L salt sensitivity-associated genotype had (mean ± SEM) higher systolic (142 ± 0.4 vs. 141 ± 0.1 mmHg, P = 0.002) and diastolic (86.0 ± 0.5 vs. 85.6 ± 0.2 mmHg, P = 0.025) blood pressure and multivariate adjusted hazards ratio (95% confidence interval) of CVD 1.13 (1.02–1.25, P = 0.018), coronary events 1.20 (1.06–1.37; P = 0.005) and cardiovascular mortality 1.17 (0.99–1.37; P = 0.055) than noncarriers but there was no significant difference in the incidence of stroke and total mortality. Conclusion: The NEDD4L salt sensitivity-associated genotype was associated with higher blood pressure, which may translate into increased risk for CVD morbidity and mortality. Interestingly, there was no association with stroke suggesting that the association is partially blood pressure independent.

[1]  Thomas J. Wang,et al.  Vasoactive Peptides with Angiogenesis-Regulating Activity Predict Cancer Risk in Males , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[2]  Kirsten Bibbins-Domingo,et al.  Projected effect of dietary salt reductions on future cardiovascular disease. , 2010, The New England journal of medicine.

[3]  G. MacGregor,et al.  A comprehensive review on salt and health and current experience of worldwide salt reduction programmes , 2009, Journal of Human Hypertension.

[4]  J. Stokes,et al.  Salt-sensitive hypertension and cardiac hypertrophy in mice deficient in the ubiquitin ligase Nedd4-2. , 2008, American journal of physiology. Renal physiology.

[5]  A. Schwab,et al.  Aldosterone and amiloride alter ENaC abundance in vascular endothelium , 2008, Pflügers Archiv - European Journal of Physiology.

[6]  G. Berglund,et al.  Blood Pressure in Relation to the Incidence of Cerebral Infarction and Intracerebral Hemorrhage: Hypertensive Hemorrhage: Debated Nomenclature Is Still Relevant , 2007, Stroke.

[7]  O. Melander,et al.  Polymorphism in NEDD4L Is Associated with Increased Salt Sensitivity, Reduced Levels of P-renin and Increased Levels of Nt-proANP , 2007, PloS one.

[8]  N. Cook,et al.  Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP) , 2007, BMJ : British Medical Journal.

[9]  O. Melander,et al.  Moderate salt restriction effectively lowers blood pressure and degree of salt sensitivity is related to baseline concentration of renin and N-terminal atrial natriuretic peptide in plasma , 2007, Journal of hypertension.

[10]  R. Toto,et al.  Epithelial sodium channel inhibition in cardiovascular disease. A potential role for amiloride. , 2007, American journal of hypertension.

[11]  E. Frohlich,et al.  Long-term mineralocorticoid receptor blockade reduces fibrosis and improves cardiac performance and coronary hemodynamics in elderly SHR. , 2007, American journal of physiology. Heart and circulatory physiology.

[12]  E. Mervaala,et al.  Sodium intake and hypertension. , 2006, Progress in cardiovascular diseases.

[13]  P. Almgren,et al.  24-h ambulatory blood pressure is linked to chromosome 18q21-22 and genetic variation of NEDD4L associates with cross-sectional and longitudinal blood pressure in Swedes. , 2006, Kidney international.

[14]  Alan D. Lopez,et al.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.

[15]  E. Frohlich,et al.  Myocardial fibrosis, impaired coronary hemodynamics, and biventricular dysfunction in salt-loaded SHR. , 2006, American journal of physiology. Heart and circulatory physiology.

[16]  G. Berglund,et al.  Incident coronary events and case fatality in relation to common carotid intima‐media thickness , 2005, Journal of internal medicine.

[17]  G. Berglund,et al.  Incidence of stroke is related to carotid IMT even in the absence of plaque. , 2005, Atherosclerosis.

[18]  R. Kass,et al.  Regulation of the voltage-gated cardiac sodium channel Nav1.5 by interacting proteins. , 2005, Trends in cardiovascular medicine.

[19]  Marc A. Thomas,et al.  Cardiac Voltage-Gated Sodium Channel Nav1.5 Is Regulated by Nedd4-2 Mediated Ubiquitination , 2004, Circulation research.

[20]  R. Schmieder,et al.  Salt intake, blood pressure, and cardiovascular structure , 1994, Cardiovascular Drugs and Therapy.

[21]  G. Simon Experimental evidence for blood pressure-independent vascular effects of high sodium diet. , 2003, American journal of hypertension.

[22]  G. MacGregor,et al.  Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health , 2002, Journal of Human Hypertension.

[23]  A. Mimran,et al.  Dietary sodium and target organ damage in essential hypertension. , 2002, American journal of hypertension.

[24]  L. Schild,et al.  Epithelial sodium channel and the control of sodium balance: interaction between genetic and environmental factors. , 2002, Annual review of physiology.

[25]  G. Berglund,et al.  The Malmö diet and cancer study: representativity, cancer incidence and mortality in participants and non‐participants , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[26]  C. Tauxe,et al.  Distinct characteristics of two human Nedd4 proteins with respect to epithelial Na(+) channel regulation. , 2001, American journal of physiology. Renal physiology.

[27]  G. Berglund,et al.  Geographic Distribution of Stroke Incidence Within an Urban Population: Relations to Socioeconomic Circumstances and Prevalence of Cardiovascular Risk Factors , 2001, Stroke.

[28]  J. Tuomilehto,et al.  Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study , 2001, The Lancet.

[29]  G. Bray,et al.  Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. , 2001, The New England journal of medicine.

[30]  A. Bihorac,et al.  Association between salt sensitivity and target organ damage in essential hypertension. , 2000, American journal of hypertension.

[31]  P. Verkade,et al.  Apical Membrane Targeting of Nedd4 Is Mediated by an Association of Its C2 Domain with Annexin Xiiib , 2000, The Journal of cell biology.

[32]  Orton,et al.  EFFECTS ON BLOOD PRESSURE OF REDUCED DIETARY SODIUM AND THE DIETARY APPROACHES TO STOP HYPERTENSION ( DASH ) DIET , 2000 .

[33]  S. Oparil,et al.  Dietary salt reduction in hypertension--what is the evidence and why is it still controversial? , 1999, Progress in cardiovascular diseases.

[34]  J. Gu,et al.  Sodium induces hypertrophy of cultured myocardial myoblasts and vascular smooth muscle cells. , 1998, Hypertension.

[35]  H. Yeger,et al.  The C2 Domain of the Ubiquitin Protein Ligase Nedd4 Mediates Ca2+-dependent Plasma Membrane Localization* , 1997, The Journal of Biological Chemistry.

[36]  T. Fujii,et al.  Sodium sensitivity and cardiovascular events in patients with essential hypertension , 1997, The Lancet.

[37]  H. Garty,et al.  Epithelial sodium channels: function, structure, and regulation. , 1997, Physiological reviews.

[38]  R. Schmieder Dietary salt intake and left ventricular hypertrophy. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[39]  L. Svetkey,et al.  Heritability of salt sensitivity in black Americans. , 1996, Hypertension.

[40]  M. Weinberger,et al.  Salt sensitivity of blood pressure in humans. , 1996, Hypertension.

[41]  M. Kupari,et al.  Correlates of left ventricular mass in a population sample aged 36 to 37 years. Focus on lifestyle and salt intake. , 1994, Circulation.

[42]  Professor Göran Berglund The Malmö Diet and Cancer Study Design, biological bank and biomarker programme , 1993 .

[43]  E. Frohlich,et al.  Relationship between dietary sodium intake, hemodynamics, and cardiac mass in SHR and WKY rats. , 1993, The American journal of physiology.

[44]  Minisymposium: The Malmö Diet and Cancer Study. Design, biological bank and biomarker programme. 23 October 1991, Malmo, Sweden. , 1993, Journal of Internal Medicine.

[45]  I. Perry,et al.  Salt intake and stroke: a possible direct effect. , 1992, Journal of human hypertension.

[46]  D E Manyari,et al.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.

[47]  Ralph B. D'Agostino,et al.  Blood Pressure as a Risk Factor for Cardiovascular Disease The Framingham Study—30 Years of Follow‐up , 1989, Hypertension.

[48]  R. Schmieder,et al.  Dietary salt intake. A determinant of cardiac involvement in essential hypertension. , 1988, Circulation.